Biotech / Finance

Shire’s HAE drug Cinryze secures label extension in Europe

From PBR - News
March 17, 2017 - 3:51am
Shire has secured label expansion approval from the European Commission for its hereditary angioedema therapy Cinryze.


Continue reading this article »